EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Meet the Contributors →

Latest News

  1. 1.

    Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More | National

  2. 2.

    Epizyme’s Soft Tissue Cancer Drug Granted Speedy FDA Approval | Boston

  3. 3.

    After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune | National

  4. 4.

    FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs | Boston

  5. 5.

    Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment | National

  6. 6.

    Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits | New York

Learn about the Xconomists →

Xconomist Forum

Featured Event

Xcelerating Life Sciences San Diego

March 18, 2020

Deal of the Day

$1.1B

Eli Lilly/Dermira

People on the Move

Kura Oncology Chief Medical Officer Plans to Step Down Next Month

Poxel Picks Sigilon’s Moller for Chief Scientific Officer Post

More News

The Feed

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2020, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.